RAP-功能化生物模拟纳米配方,具有病理性ROS/pH响应药物释放,用于质瘤向免疫治疗.
Yunfan Li1,2, Kaiwen Bao1,2, Renzheng Huan1,2
1Department of Neuro-Oncology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, 400030, Chongqing, China.
Journal of nanobiotechnology
|February 7, 2026
概括
这项研究介绍了一种用于质母细胞瘤 (GBM) 治疗的新型纳米药物 (RMM@GEM NPs). RMM@GEM NPs增强了跨血脑屏障的药物输送,激活了抗瘤免疫力并改善了治疗结果.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 质母细胞瘤 (GBM) 是一种高度攻击性的脑瘤,预后不佳.
- 葛西他 (GEM) 显示出抗癌活性,但在穿越血脑屏障 (BBB) 方面面临挑战.
- 在GBM中瘤微环境通常具有免疫抑制作用,阻碍有效治疗.
研究的目的:
- 开发一种双响应生物模拟纳米药物,用于增强GBM治疗.
- 为了改善BBB透率和凝胺的向输送.
- 为了激活抗瘤免疫反应并克服瘤免疫抑制.
主要方法:
- 使用质母细胞瘤细胞膜和向酸RAP的RMM@GEMNP的制造.
- 对RMM@GEMNP的BBB透和瘤积累的评估.
- 评估由瘤微环境刺激 (ROS,酸度) 触发的GEM释放.
- 分析STING通路激活和免疫细胞调节 (PD-L1,T细胞耗尽).
主要成果:
- RMM@GEM NPs在质瘤病变中展示了有效的BBB透和选择性积累.
- 双响应性药物释放激活了STING信号通路 (p-STING,p-TBK1,p-IRF3,p-NF-κB). 药物释放激活了STING信号通路 (p-STING,p-TBK1,p-IRF3,p-NF-κB). 药物释放激活了STING信号通路 (p-STING,p-TBK1,p-IRF3,p-NF-κB).
- 胆固醇消耗抑制了PD-L1表达,缓解了T细胞疲劳,增强了抗瘤免疫力.
结论:
- RMM@GEM NPs代表了增强"冷"GBM瘤中的免疫反应的有希望的策略.
- 这种方法为GBM治疗中有效和安全的免疫疗法提供了潜在的途径.
- 双响应生物模拟纳米药物设计具有克服脑瘤治疗挑战的潜力.
相关概念视频
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K
02:43Peptide Bonds
83.3K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.3K
01:22Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
01:26Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
01:21Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K